In 1995 the World Health Organization (WHO) estimated that there were 300,000 new cases of HAT in Africa each year. 2 Eradication programs have seen this number fall sharply with 3679 cases of WAT 3 and 118 cases of EAT reported in 2014, 4 however, 55.1 million people are still at risk of the disease. 3 Cases diagnosed outside of Africa number <50 for both WAT and EAT each year. 5 Due to its low incidence and non-specific clinical features, diagnosis of HAT can be challenging. Definitive diagnosis of HAT relies on isolation of the trypanosomes from blood, lymph node aspirate or cerebrospinal fluid (CSF) in the case of Stage 2 disease, though serological and PCR diagnostic methods are of increasing value. Due to the paucity of MRI in endemic countries, its role in diagnosis of HAT aBstRaCt Human African Trypanosomiasis (HAT) is a neglected tropical disease that affected 3797 people worldwide in 2014. Without treatment mortality approaches 100%. Due to its low incidence and non-specific clinical features, diagnosis can be challenging and the role of MRI in diagnosis of HAT has not been evaluated outside of case reports. We carried out a retrospective, institutional review of three patients presenting with neurological stage (Stage 2) HAT presenting to the Hospital of Tropical Diseases, London between 2004 and 2016. MRI brain was performed in both the acute and follow-up stages of their infection. In addition to confirming that the most common MRI abnormality is T 2 weighted fluid-attenuated inversion recovery (T2W FLAIR) high signal intensity in the supratentorial white matter, this series has identified radiological findings not previously reported in the literature. In the acute stages, restricted diffusion can be seen in the internal capsules and splenium of the corpus callosum and microhaemorrhages not related to melarsoprol have been identified. Furthermore, the signal abnormality appears to be largely reversible upon treatment with regression associated with mild atrophy demonstrated on follow-up MRI post-treatment. We conclude that although direct microscopy remains the mainstay of diagnosis with serological and polymerase chain reaction (PCR) testing providing useful adjuncts, MRI brain can be helpful in assessing neurological involvement and may provide important prognostic information post-treatment.
has not been evaluated outside of case reports. Here we report a case series of three patients (two WAT and one EAT) who presented to the Hospital of Tropical Diseases, London between 2004 and 2016 who underwent MRI imaging in both the acute and follow-up stages of their infection.
Clinical aspects of these cases have already been reported in the literature by our institution. [6] [7] [8] Case Review Case 1-West African Trypanosomiasis A 58-year-old Nigerian national living in the Delta state presented to a district general hospital in the UK in August 2016 with a history of fever, confusion and drowsiness. Her illness had started in January 2016 with lethargy and tremors and for the previous 2 months this had progressed to unsteadiness on walking, 18 kg weight loss and increasing malaise. On arrival she had no focal neurology, signs of meningism or lymphadenopathy but was found to have poor co-ordination with myoclonic jerks and bradyphrenia.
Her admission bloods showed a white cell count (WCC) of 5. She was initiated on antiviral and antituberculous treatment.
Due to her deteriorating condition serum was sent for T.b. gambiense Indirect Fluorescent Antibody Test which was positive at 1:400 and she was transferred to the Hospital for Tropical Diseases. Repeat lumbar puncture (LP) on admission showed a WCC of 1140 (90% mononuclear), a protein of 1.14 g l −1 and a glucose of 2.3 mmol l −1 (serum 5.5). CSF T.b. gambiense IFAT was positive at 1:4. No trypanosomes were detected in peripheral blood or CSF. PCR of CSF and serum was positive with primers specific for T.b. gambiense Type 1.
MRI was performed with a T 2 weighted fluid-attenuated inversion recovery (T2W FLAIR) sequence demonstrating diffuse, symmetrical high signal intensity of the deep white matter involving the basal ganglia and splenium of the corpus callosum (Figure 1a) . Diffusion-weighted imaging (Figure 1b Admission CSF showed a WCC of 250 (100% mononuclear) and a protein of 0.57 g l −1 with a normal CSF/serum glucose ratio. Herpes virus PCR was negative.
HIV and syphilis serology were negative. He was found to have high levels of voltage gated potassium channel-complex antibodies with moderate levels of N-methyl-D-aspartate antibodies. He was initially treated with i.v. acyclovir and ceftriaxone with no effect.
He suffered a generalised tonic-clonic seizure and unresponsiveness that required intubation and intensive therapy unit (ITU) admission. Microscopy of a bone marrow trephine revealed Trypomastigotes of T. brucei, which were subsequently seen in peripheral blood.
He was transferred to the Hospital for Tropical Diseases and commenced on nifurtimox/eflornithine combination therapy as per the WHO guidelines for a Stage 2 WAT. Repeat CSF showed a positive T.b. gambiense IFAT at 1:32 and a serum IFAT was positive at 1:3200.
T2W FLAIR MRI performed on transfer showed bilateral supratentorial deep white matter high signal intensity (Figure 2a) extending to involve the cerebellum and brain stem (Figure 2b ) as well as the mesial temporal lobe structures. The ventricles appeared prominent for his age. 4 days into treatment he was extubated with reversal of his coma and he was transferred to the ward. On day 9 of treatment he became drowsy. CSF showed no evidence of trypanosomes. Given his previously high VGKC-complex antibodies he was treated with 9 cycles of plasma exchange with good effect.
At 1-month post-discharge his mobility and cognition had improved and his extrapyramidal symptoms had resolved. An MRI performed 3 months following the initial scan showed new blooming artefact on SWI in the pons, putamen and thalamus (Figure 2c ) with improvement in the deep white matter signal abnormality and residual high signal in the hippocampi (Figure 2d ).
Case 3-East African Trypanosomiasis
A 38-year-old British male presented to a South African hospital in August 2004 after 2 years of travelling in South Africa, Malawi, Mozambique and Namibia. He presented with a 4-month history of progressive fatigue, fever, headache and sleeplessness.
On arrival he was found to be febrile with mild hepatomegaly and lymphadenopathy. Bloods showed raised inflammatory markers with a CRP of 54 mg l −1 and an of 120. CSF showed a raised protein at 1.2 g l −1 with a glucose level of 2.1 mmol l −1
, the WCC was 82 (100% mononuclear). CT head was unremarkable.
An HIV test was negative. A blood film was positive for trypanosomes and a diagnosis of Stage 2 EAT was made. He was treated with suramin and melarsoprol with prednisolone cover. He made a full recovery and 2 weeks post-treatment his CSF had normalised.
In June 2005 he reported a 2-month history of headache, night sweats, somnolence and fever. Repeat LP showed a WCC of 58 (100% mononuclear), a protein of 0.79 g l −1 and a glucose of 2.9 mmol l −1 . Blood and CSF showed no trypanosomes. He was treated as a relapsed trypanosomiasis and was commenced on a 2-week course of eflornithine from which he made a rapid recovery. His CSF WCC count fell to normal levels by August 2005.
In December 2005 he presented with a 2-week history of headache, fever, vertigo, diplopia and somnolence. He had a left sixth nerve palsy on examination. LP showed trypanosomes in his CSF with a WCC of 125 (100% mononuclear), a protein of 0.8 g l −1 and a glucose of 3.1 mmol l −1
. His blood was positive for trypanosomes. He was treated with a repeat course of suramin and melarsoprol with prednisolone cover for relapsed Stage 2 EAT.
On day 16 of his treatment he became confused and suffered a generalised tonic-clonic seizure. LP showed an opening pressure . An MRI at this time demonstrated T2W hyperintense signal in the supratentorial white matter extending into the posterior limbs of the internal capsules and splenium of the corpus callosum (Figure 3a) , both of which showed corresponding restricted diffusion (Figure 3b,c) . Post-contrast sequences revealed mild ependymal enhancement of the occipital horns of the lateral ventricles with no parenchymal enhancement (Figure 3d) . Focal signal loss on T 2 -star (T 2 *) imaging was also present in the splenium of the corpus callosum and basal ganglia (Figure 3e ) in keeping with microhaemorrhages and he was transferred to ITU where he was sedated and intubated.
Follow-up imaging 6 months later showed residual but reduced T2W FLAIR signal hyperintensity in the deep white matter, resolution of the restricted diffusion abnormalities and mild supratentorial atrophy when compared to his admission MRI (Figure 3f ).
DisCussioN
The most consistent brain MRI finding in the three cases presented is diffuse symmetrical deep white matter T2W FLAIR hyperintensity with less striking involvement of the splenium of the corpus callosum, basal ganglia, mid brain and pons. Follow-up imaging post-treatment demonstrated marked regression of the signal abnormality associated with mild atrophy in two of the three cases over a 4 to 6-month period.
The imaging findings in HAT have been described as far back as 1989-a literature review identified 13 publications (12 unique patients) with specific reference to MRI findings of the brain. Seven patients were diagnosed with WAT, four with EAT and one unknown ( Table 1 ).
All published cases of MRI in HAT have symmetrical high T2W FLAIR signal abnormalities of the deep white matter tracts, with involvement of the basal nuclei seen less frequently in only 6 of the 12 cases. 10, 14, 15, 17, 18, 20 Signal abnormalities of the cerebellum and brainstem occurred in just over half of published reports (seven cases 10, 12, [16] [17] [18] [19] [20] with ventricular enlargement and varying degrees of improvement in signal abnormalities in the four cases that had follow-up imaging. 10, 14, 17, 20 The signal abnormality may be the result of perivascular infiltration with surrounding areas of demyelination and axonal damage as seen on autopsy. 15 Atrophy of the brain -thought not to be described in autopsy reports as the patients usually had active disease -is only apparent as a late effect with MRI demonstrating these changes particularly well. 17 Microhaemorrhage on MRI, seen as blooming artefact on SWI and T2*W imaging, is seen in the three cases presented in this series. In the first case, microhaemorrhages were seen in the globus pallidus, left internal capsule and left periventricular deep white matter while the second demonstrated smaller foci in the pons, thalamus and putamen. Cerebral microhaemorrhage and axonal injury have been described in the chronic stages of the disease on histopathology 21 and these findings have not been previously reported on MRI in HAT. At our institution, a haemorrhage sensitive sequence is part of our routine diagnostic MRI brain protocol and it may be that this radiological finding may have been previously under-reported in this disease. Indeed, 
